CoolClinical.com has Developed the First AI System for Predicting Outcomes of Cancer Treatment

Cool Clinical announced the release of the publication on the first Artificial Intelligence system for predicting outcomes of cancer treatment, using data from clinical trials. This is a breakthrough for AI approaches to cancer treatment, because clinical trial data are widely available; this research therefore shows the way for precision medicine systems for cancer which are very feasible to develop.

The subject was treatment of prostate cancer by the common drug bicalutamide ("Casodex"). Treatment outcomes were predicted two years in advance, based on data collected at the start of treatment in 3653 patients. While the research was focused on prostate cancer, the techniques are generally applicable.

"What we have been able to achieve using Artificial Intelligence is almost like magic," says Dr Felix Beacher, Founder of Cool Clinical. "Responses to drugs vary greatly. But by predicting treatment outcomes, we could select the right drug for a particular patient. This could dramatically improve the safety and effectiveness of drugs, even without making any changes to them. This is the essence of precision medicine."

"Some have suggested that this kind of approach could be a threat to drug companies. I don't think that's true. Companies who embrace this kind of innovation have a great opportunity. Such AI-based approaches are the future. Nothing can change that. These kinds of approaches will sharpen competition and drive innovation in medicine. That's entirely a positive thing, because ultimately it will benefit patients."

The research has just been published in the journal Algorithms, 5 May 2021.
https://www.mdpi.com/1999-4893/14/5/147 (early access version)
https://www.mdpi.com/1999-4893/14/5/147/pdf (full pdf)

About CoolClinical.com

Cool Clinical is a consortium of clinical and computational scientists, dedicated to developing Artificial Intelligence (AI) approaches to cancer. To learn more, please visit www.coolclinical.com.

Most Popular Now

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

New AI Approach Paves Way for Smarter T-…

Researchers have harnessed the power of artificial intelligence (AI) to tackle one of the most complex challenges in immunology: predicting how T cells recognize and respond to specific peptide antigens...

Study Used AI Models to Improve Predicti…

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...